|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.57 |
7.17 |
-10.84 |
1 |
4 |
0 |
45 |
272.739 |
2 |
↓
|
Hi
High (pH 8-9.5)
|
3.57 |
6.75 |
-41.88 |
0 |
4 |
-1 |
43 |
271.731 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 26 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KPCE-4-E |
Protein Kinase C Epsilon (cluster #4 Of 5), Eukaryotic |
Eukaryotes |
24 |
0.41 |
Binding ≤ 10μM
|
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
4630 |
0.29 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.75 |
9.03 |
-30.15 |
0 |
5 |
1 |
41 |
348.378 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 29 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.30 |
8.49 |
-20.4 |
4 |
3 |
1 |
56 |
314.412 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.36 |
-2.14 |
-16.54 |
5 |
9 |
0 |
150 |
356.367 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 150 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.90 |
5.39 |
-13.16 |
0 |
2 |
0 |
26 |
180.21 |
0 |
↓
|
Lo
Low (pH 4.5-6)
|
1.90 |
5.91 |
-29.73 |
1 |
2 |
1 |
27 |
181.218 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 8 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KCNH2-2-E |
HERG (cluster #2 Of 5), Eukaryotic |
Eukaryotes |
210 |
0.33 |
Binding ≤ 10μM
|
S22A1-1-E |
Solute Carrier Family 22 Member 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5000 |
0.27 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
9940 |
0.25 |
Binding ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
720 |
0.31 |
Binding ≤ 10μM |
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Functional ≤ 10μM
|
ADO-1-E |
Aldehyde Oxidase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6400 |
0.26 |
ADME/T ≤ 10μM
|
CP2D6-2-E |
Cytochrome P450 2D6 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
7500 |
0.26 |
ADME/T ≤ 10μM
|
Z103205-3-O |
A431 (cluster #3 Of 4), Other |
Other |
5890 |
0.26 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
600 |
0.31 |
Functional ≤ 10μM
|
Z50460-4-O |
Leishmania Major (cluster #4 Of 4), Other |
Other |
1500 |
0.29 |
Functional ≤ 10μM
|
Z80064-8-O |
CCRF-CEM (T-cell Leukemia) (cluster #8 Of 9), Other |
Other |
139 |
0.34 |
Functional ≤ 10μM
|
Z80084-1-O |
CEM-VLB (Vinblastine-resistant T-cell Leukemia Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.31 |
Functional ≤ 10μM
|
Z80085-1-O |
CEM-VM1 (Etoposide-resistant T-cell Leukemia Cells) (cluster #1 Of 2), Other |
Other |
1910 |
0.29 |
Functional ≤ 10μM
|
Z80089-1-O |
CHO-AA8 (cluster #1 Of 2), Other |
Other |
1 |
0.45 |
Functional ≤ 10μM
|
Z80115-1-O |
DC3F (cluster #1 Of 1), Other |
Other |
4 |
0.42 |
Functional ≤ 10μM
|
Z80117-2-O |
DC3F/AD-II (cluster #2 Of 2), Other |
Other |
47 |
0.37 |
Functional ≤ 10μM
|
Z80152-1-O |
HCT-8 (Ileocecal Adenocarcinoma) (cluster #1 Of 2), Other |
Other |
120 |
0.35 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
6 |
0.41 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
559 |
0.31 |
Functional ≤ 10μM |
Z80186-6-O |
K562 (Erythroleukemia Cells) (cluster #6 Of 11), Other |
Other |
23 |
0.38 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
50 |
0.37 |
Functional ≤ 10μM
|
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
75 |
0.36 |
Functional ≤ 10μM
|
Z80227-2-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
1165 |
0.30 |
Functional ≤ 10μM
|
Z80244-7-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #7 Of 7), Other |
Other |
490 |
0.32 |
Functional ≤ 10μM
|
Z80322-1-O |
NCI-H358 (Lung Carcinama Cells) (cluster #1 Of 2), Other |
Other |
150 |
0.34 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
890 |
0.30 |
Functional ≤ 10μM
|
Z80475-3-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #3 Of 3), Other |
Other |
60 |
0.36 |
Functional ≤ 10μM
|
Z80601-1-O |
XRS6 (cluster #1 Of 1), Other |
Other |
240 |
0.33 |
Functional ≤ 10μM
|
Z80608-4-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #4 Of 4), Other |
Other |
180 |
0.34 |
Functional ≤ 10μM
|
Z80612-1-O |
2008 (Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
4310 |
0.27 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
3520 |
0.27 |
Functional ≤ 10μM
|
Z80712-7-O |
T47D (Breast Carcinoma Cells) (cluster #7 Of 7), Other |
Other |
220 |
0.33 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
1485 |
0.29 |
Functional ≤ 10μM |
Z80846-2-O |
F460pv8/eto Cell Line (cluster #2 Of 2), Other |
Other |
40 |
0.37 |
Functional ≤ 10μM
|
Z80889-2-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
210 |
0.33 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
700 |
0.31 |
Functional ≤ 10μM
|
Z81024-8-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #8 Of 8), Other |
Other |
60 |
0.36 |
Functional ≤ 10μM
|
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
100 |
0.35 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
80 |
0.35 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
12 |
0.40 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
12 |
0.40 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
12 |
0.40 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
901 |
0.30 |
Functional ≤ 10μM |
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
9500 |
0.25 |
Functional ≤ 10μM
|
Z81252-10-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #10 Of 11), Other |
Other |
140 |
0.34 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
1010 |
0.30 |
Functional ≤ 10μM
|
Z81284-2-O |
NCI-H647 (cluster #2 Of 2), Other |
Other |
70 |
0.36 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.91 |
6.33 |
-44.52 |
2 |
6 |
0 |
84 |
393.468 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
4.91 |
5.83 |
-16.62 |
2 |
6 |
0 |
80 |
393.468 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
4.91 |
5.94 |
-47.33 |
1 |
6 |
-1 |
82 |
392.46 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
600 |
0.48 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.54 |
-0.38 |
-13.56 |
0 |
3 |
0 |
42 |
232.242 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ALK-1-E |
ALK Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1100 |
0.42 |
Binding ≤ 10μM |
AURKB-2-E |
Serine/threonine-protein Kinase Aurora-B (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
500 |
0.44 |
Binding ≤ 10μM |
IGF1R-1-E |
Insulin-like Growth Factor 1 Receptor (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8600 |
0.35 |
Binding ≤ 10μM |
MET-1-E |
Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4400 |
0.37 |
Binding ≤ 10μM |
PIM1-1-E |
Serine/threonine-protein Kinase PIM1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
300 |
0.46 |
Binding ≤ 10μM |
PLK1-1-E |
Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8800 |
0.35 |
Binding ≤ 10μM |
UFO-1-E |
Tyrosine-protein Kinase Receptor UFO (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6600 |
0.36 |
Binding ≤ 10μM |
VGFR2-1-E |
Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
800 |
0.43 |
Binding ≤ 10μM |
Z80208-1-O |
L5178Y (Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
400 |
0.45 |
Functional ≤ 10μM |
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
4340 |
0.38 |
Functional ≤ 10μM |
Z81057-1-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #1 Of 4), Other |
Other |
1800 |
0.40 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.39 |
-1.65 |
-12.14 |
4 |
6 |
0 |
111 |
274.228 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 15 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HDA10-1-E |
Histone Deacetylase 10 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
31 |
0.40 |
Binding ≤ 10μM |
HDA11-1-E |
Histone Deacetylase 11 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4 |
0.45 |
Binding ≤ 10μM |
HDAC1-2-E |
Histone Deacetylase 1 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
7 |
0.44 |
Binding ≤ 10μM |
HDAC2-1-E |
Histone Deacetylase 2 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
2 |
0.47 |
Binding ≤ 10μM |
HDAC3-1-E |
Histone Deacetylase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2 |
0.47 |
Binding ≤ 10μM |
HDAC4-1-E |
Histone Deacetylase 4 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
550 |
0.34 |
Binding ≤ 10μM
|
HDAC5-1-E |
Histone Deacetylase 5 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
80 |
0.38 |
Binding ≤ 10μM
|
HDAC6-1-E |
Histone Deacetylase 6 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2 |
0.47 |
Binding ≤ 10μM
|
HDAC7-1-E |
Histone Deacetylase 7 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4550 |
0.29 |
Binding ≤ 10μM
|
HDAC8-1-E |
Histone Deacetylase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
22 |
0.41 |
Binding ≤ 10μM |
HDAC9-1-E |
Histone Deacetylase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
3200 |
0.30 |
Binding ≤ 10μM
|
Q9XYC7-1-E |
Histone Deacetylase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.47 |
Binding ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
21 |
0.41 |
Functional ≤ 10μM
|
Z80390-3-O |
PC-3 (Prostate Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
24 |
0.41 |
Functional ≤ 10μM |
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
48 |
0.39 |
Functional ≤ 10μM |
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
35 |
0.40 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.19 |
6.33 |
-22.79 |
4 |
5 |
0 |
77 |
349.434 |
7 |
↓
|
Ref
Reference (pH 7)
|
3.37 |
5.51 |
-52.21 |
5 |
5 |
1 |
85 |
350.442 |
7 |
↓
|
Hi
High (pH 8-9.5)
|
3.19 |
7.58 |
-62.39 |
3 |
5 |
-1 |
80 |
348.426 |
7 |
↓
|
|
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 36 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5300 |
0.23 |
Binding ≤ 10μM
|
Z100250-1-O |
Calf Thymus DNA (cluster #1 Of 2), Other |
Other |
400 |
0.28 |
Binding ≤ 10μM
|
Z50380-1-O |
Mycobacterium Smegmatis (cluster #1 Of 4), Other |
Other |
9700 |
0.22 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
1259 |
0.26 |
Functional ≤ 10μM
|
Z50587-1-O |
Homo Sapiens (cluster #1 Of 9), Other |
Other |
10 |
0.35 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
26 |
0.33 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
3600 |
0.24 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6 |
0.36 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1 |
0.39 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
8200 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
66 |
0.31 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
8700 |
0.22 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
7 |
0.36 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
10 |
0.35 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
10 |
0.35 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
9 |
0.35 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
30 |
0.33 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
28 |
0.33 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
12 |
0.35 |
Functional ≤ 10μM
|
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6 |
0.36 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
4 |
0.37 |
Functional ≤ 10μM
|
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
395 |
0.28 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
7 |
0.36 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.33 |
Functional ≤ 10μM
|
Z80463-1-O |
SCOV-3 (cluster #1 Of 1), Other |
Other |
5 |
0.36 |
Functional ≤ 10μM |
Z80475-2-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #2 Of 3), Other |
Other |
16 |
0.34 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
9800 |
0.22 |
Functional ≤ 10μM
|
Z80601-1-O |
XRS6 (cluster #1 Of 1), Other |
Other |
10 |
0.35 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
8000 |
0.22 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
3 |
0.37 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
7200 |
0.22 |
Functional ≤ 10μM
|
Z81017-2-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
8 |
0.35 |
Functional ≤ 10μM
|
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
6 |
0.36 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
20 |
0.34 |
Functional ≤ 10μM
|
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
646 |
0.27 |
Functional ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
100 |
0.31 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
960 |
0.26 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
48 |
0.32 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
27 |
0.33 |
Functional ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
8000 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.36 |
-2.16 |
-97.76 |
10 |
10 |
2 |
172 |
446.504 |
12 |
↓
|
Hi
High (pH 8-9.5)
|
0.36 |
-3.57 |
-51.37 |
9 |
10 |
1 |
168 |
445.496 |
12 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 31 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.19 |
6.98 |
-9.07 |
0 |
3 |
0 |
39 |
233.274 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
71 |
0.45 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
71 |
0.45 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
71 |
0.45 |
Functional ≤ 10μM
|
Z80017-2-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
570 |
0.40 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
2300 |
0.36 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
990 |
0.38 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
98 |
0.45 |
Functional ≤ 10μM
|
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
3800 |
0.34 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
98 |
0.45 |
Functional ≤ 10μM
|
Z80493-3-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #3 Of 6), Other |
Other |
980 |
0.38 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
530 |
0.40 |
Functional ≤ 10μM
|
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
510 |
0.40 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
580 |
0.40 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
190 |
0.43 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
189 |
0.43 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.34 |
-0.53 |
-51.34 |
2 |
4 |
1 |
46 |
294.378 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.27 |
-0.66 |
-50.22 |
2 |
4 |
1 |
46 |
328.823 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HDA10-1-E |
Histone Deacetylase 10 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
23 |
0.41 |
Binding ≤ 10μM |
HDA11-1-E |
Histone Deacetylase 11 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
24 |
0.41 |
Binding ≤ 10μM |
HDAC1-2-E |
Histone Deacetylase 1 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
77 |
0.38 |
Binding ≤ 10μM |
HDAC2-1-E |
Histone Deacetylase 2 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
27 |
0.41 |
Binding ≤ 10μM |
HDAC3-1-E |
Histone Deacetylase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
19 |
0.42 |
Binding ≤ 10μM |
HDAC4-1-E |
Histone Deacetylase 4 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
16 |
0.42 |
Binding ≤ 10μM |
HDAC5-1-E |
Histone Deacetylase 5 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
21 |
0.41 |
Binding ≤ 10μM |
HDAC6-1-E |
Histone Deacetylase 6 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
247 |
0.36 |
Binding ≤ 10μM |
HDAC7-1-E |
Histone Deacetylase 7 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
104 |
0.38 |
Binding ≤ 10μM |
HDAC8-1-E |
Histone Deacetylase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
48 |
0.39 |
Binding ≤ 10μM |
HDAC9-1-E |
Histone Deacetylase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
24 |
0.41 |
Binding ≤ 10μM |
CP2CJ-1-E |
Cytochrome P450 2C19 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
5780 |
0.28 |
ADME/T ≤ 10μM |
CP3A4-2-E |
Cytochrome P450 3A4 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
2730 |
0.30 |
ADME/T ≤ 10μM |
Z100405-1-O |
MV4-11 (Myeloid Leukemia Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.38 |
Functional ≤ 10μM |
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
340 |
0.35 |
Functional ≤ 10μM |
Z80415-1-O |
Ramos (Burkitts Lymhoma B-cells) (cluster #1 Of 1), Other |
Other |
140 |
0.37 |
Functional ≤ 10μM |
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
480 |
0.34 |
Functional ≤ 10μM |
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
480 |
0.34 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.49 |
9.6 |
-62.75 |
3 |
6 |
1 |
72 |
359.494 |
10 |
↓
|
Hi
High (pH 8-9.5)
|
3.49 |
7.49 |
-18.21 |
2 |
6 |
0 |
70 |
358.486 |
10 |
↓
|
Lo
Low (pH 4.5-6)
|
3.49 |
9.9 |
-112.62 |
4 |
6 |
2 |
73 |
360.502 |
10 |
↓
|
|